Oncotarget

Research Papers:

Cancer stem cells from peritumoral tissue of glioblastoma multiforme: the possible missing link between tumor development and progression

Cristiana Angelucci, Alessio D’Alessio _, Gina Lama, Elena Binda, Annunziato Mangiola, Angelo L. Vescovi, Gabriella Proietti, Laura Masuelli, Roberto Bei, Barbara Fazi, Silvia Anna Ciafrè and Gigliola Sica

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:28116-28130. https://doi.org/10.18632/oncotarget.25565

Metrics: PDF 1061 views  |   HTML 1180 views  |   ?  


Abstract

Cristiana Angelucci1,*, Alessio D’Alessio1,*, Gina Lama1, Elena Binda2, Annunziato Mangiola3, Angelo L. Vescovi4,5,6, Gabriella Proietti1, Laura Masuelli7, Roberto Bei8, Barbara Fazi9, Silvia Anna Ciafrè9 and Gigliola Sica1

1Istituto di Istologia ed Embriologia, Università Cattolica del Sacro Cuore-Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy

2Cancer Stem Cells Unit, IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, Opera di San Pio da Pietrelcina, S. Giovanni Rotondo, Foggia, Italy

3Istituto di Neurochirurgia, Università Cattolica del Sacro Cuore–Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy

4Department of Biotechnology and Biosciences, University of Milan Bicocca, Milan, Italy

5IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, Opera di San Pio da Pietrelcina, S. Giovanni Rotondo, Foggia, Italy

6Hyperstem SA, Lugano, Switzerland

7Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

8Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy

9Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

*These authors contributed equally to this work

Correspondence to:

Alessio D’Alessio, email: alessio.dalessio@unicatt.it

Keywords: glioblastoma cancer stem cells; peritumoral cancer stem cells; stemness markers; proliferation and invasiveness markers; H19 lncRNA and miR-675-5p

Received: May 31, 2017     Accepted: May 19, 2018     Published: June 15, 2018

ABSTRACT

In glioblastoma multiforme (GBM), cancer stem cells (CSCs) are thought to be responsible for gliomagenesis, resistance to treatment and recurrence. Unfortunately, the prognosis for GBM remains poor and recurrence frequently occurs in the peritumoral tissue within 2 cm from the tumor edge. In this area, a population of CSCs has been demonstrated which may recapitulate the tumor after surgical resection. In the present study, we aimed to characterize CSCs derived from both peritumoral tissue (PCSCs) and GBM (GCSCs) in order to deepen their significance in GBM development and progression. The stemness of PCSC/GCSC pairs obtained from four human GBM surgical specimens was investigated by comparing the expression of specific stem cell markers such as Nestin, Musashi-1 and SOX2. In addition, the growth rate, the ultrastructural features and the expression of other molecules such as c-Met, pMet and MAP kinases, involved in cell migration/invasion, maintenance of tumor stemness and/or resistance to treatments were evaluated. Since it has been recently demonstrated the involvement of the long non-coding RNAs (lncRNAs) in the progression of gliomas, the expression of H19 lncRNA, as well as of one of its two mature products miR-675-5p was evaluated in neurospheres. Our results show significant differences between GCSCs and PCSCs in terms of proliferation, ultrastructural peculiarities and, at a lower extent, stemness profile. These differences might be important in view of their potential role as a therapeutic target.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25565